LOGIN  |  REGISTER
Cue Biopharma

Recent Insider Transactions - Sage Therapeutics (NASDAQ: SAGE)

Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ SAGE Sage Therapeutics
Shiferman Gregory L. / officer: See Remarks
01/16/2025
Buy
$6.97
28,000
$195K
28,000
NASDAQ SAGE Sage Therapeutics
Greene Barry E / director, officer: President and CEO
01/16/2025
Buy
$6.97
174,000
$1.213M
174,000
NASDAQ SAGE Sage Therapeutics
Benecchi Christopher / officer: Chief Operating Officer
01/16/2025
Buy
$6.97
40,000
$279K
40,000
NASDAQ SAGE Sage Therapeutics
Golumbeski George / director
01/03/2025
Buy
$6.14
13,593
$83K
13,593
NASDAQ SAGE Sage Therapeutics
FRATES JAMES M / director
01/03/2025
Buy
$6.14
19,154
$118K
19,154
NASDAQ SAGE Sage Therapeutics
Shiferman Gregory L. / officer: See Remarks
12/24/2024
Sell
$5.48
79
$433
19,888